Open access · US-GOV via ClinicalTrials.gov Clinical trial

PHILUCA: The Development of Muscle Mass, Muscle Strength, and Muscle Function in Patients With Lung Cancer During Cancer Treatment

Authors not listed

Zealand University Hospital · 2024

Dysbiosis Human Randomized controlled trial

Abstract

The PHILICA study investigates whether muscle mass, muscle strength, and muscle function are associated with treatment tolerance, quality of life and survival in patients with lung cancer. It also aims to explore why some patients face challenges in completing their treatment. The findings may contribute to improved strategies for supporting patients and developing more precise and individualized treatment plans in the future.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-10-18 MST

Cite this

APA

Anonymous. (2024). PHILUCA: The Development of Muscle Mass, Muscle Strength, and Muscle Function in Patients With Lung Cancer During Cancer Treatment. <em>Zealand University Hospital</em>. https://clinicaltrials.gov/study/NCT06730685

Vancouver

Anonymous. PHILUCA: The Development of Muscle Mass, Muscle Strength, and Muscle Function in Patients With Lung Cancer During Cancer Treatment. Zealand University Hospital. 2024.

BibTeX

@misc{anon2024PHILUC, title = {PHILUCA: The Development of Muscle Mass, Muscle Strength, and Muscle Function in Patients With Lung Cancer During Cancer Treatment}, author = {Anonymous}, journal = {Zealand University Hospital}, year = {2024}, }